AVITA Medical Inc. (ASX:AVH) commercialises wound-care products including RECELL, Cohealyx and PermeaDerm for use in acute skin injury treatment. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of the …
Monash IVF Group Limited (ASX:MVF) provides assisted reproductive technology, fertility treatment and related services in Australia and selected international markets. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of …
Pacific Edge Limited (ASX:PEB) develops non-invasive diagnostic tests designed to assist the assessment and management of bladder cancer. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of the business …
Starpharma Holdings Limited (ASX:SPL) develops dendrimer-based technologies for pharmaceutical applications, including drug-delivery programs and oncology-related research. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of the business determines whether …
Mayne Pharma Group Limited (ASX:MYX) develops, manufactures and distributes pharmaceutical products, with businesses spanning women’s health, dermatology and international markets. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of …
Clarity Pharmaceuticals Limited (ASX:CU6) has dosed its planned target of 383 participants in the registrational Phase III CLARIFY trial. The study is assessing the diagnostic performance of 64Cu-SAR-bisPSMA PET imaging in people with high-risk prostate cancer who are scheduled for radical prostatectomy.
PainChek Limited (ASX:PCK) has signed an agreement with Hallmark Luxury Care Homes, a new UK customer, covering all 23 of its homes in England and Wales. The contract adds about 1,800 committed resident licences, all of which are new business for PainChek's UK operations.
NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has released its quarterly activities report and Appendix 4C for the period ended 30 September 2026. The company is advancing its StemSmart cell therapy towards a Phase 2 trial in refractory Crohn's disease.
CSL Limited develops and supplies plasma-derived therapies, influenza vaccines and medicines for kidney disease and iron deficiency across international healthcare markets. Following its FY26 results and a broad operational review, CSL Limited (ASX:CSL) shares closed at AUD 196.78 on 27 October 2026, The company …
Sigma Healthcare (ASX:SIG) combines pharmacy franchising, retail network services and pharmaceutical distribution. Chemist Warehouse branded outlets sell prescription medicines, over-the-counter products, beauty items and personal care goods. The company also supports the Amcal and Discount Drug Stores brands and supplies pharmacies through a distribution …